Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Imad Tleyjeh"'
Autor:
Faisal Alasmari, Mahmoud Mukahal, Alaa Ashraf Alqurashi, Molla Huq, Fatima Alabdrabalnabi, Abdullah AlJurayyan, Shymaa Moshobab Alkahtani, Fatimah Salem Assari, Rahaf Bashaweeh, Rana Salam, Solaf Aldera, Ohud Mohammed Alkinani, Talal Almutairi, Kholoud AlEnizi, Imad Tleyjeh
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272818 (2022)
Seroprevalence of SARS-CoV-2 IgG among health care workers (HCWs) is crucial to inform infection control programs. Conflicting reports have emerged on the longevity of SARS-CoV-2 IgG. Our objective is to describe the prevalence of SARS-CoV-2 IgG in H
Externí odkaz:
https://doaj.org/article/0a87836abb294a7a9eb9c30314ca2fef
Autor:
Fatemeh Saheb Sharif‐Askari, Hawra Ali Hussain Alsayed, Imad Tleyjeh, Narjes Saheb Sharif‐Askari, Ali Al Sayed Hussain, Basema Saddik, Qutayba Hamid, Rabih Halwani
Publikováno v:
Clinical pharmacology and therapeutics. 112(6)
Sotrovimab, an anti-severe acute respiratory syndrome-coronavirus 2 monoclonal antibody is being utilized to prevent progression of coronavirus disease 2019 (COVID-19). Therefore, to understand its benefits, we have conducted a retrospective analysis
Autor:
Faisal Alasmari, Mahmoud Mukahal, Alaa Ashraf Alqurashi, Molla Huq, Fatima Alabdrabalnabi, Abdullah AlJurayyan, Shymaa Moshobab Alkahtani, Fatimah Salem Assari, Rahaf Bashaweeh, Rana Salam, Solaf Aldera, Ohud Mohammed Alkinani, Talal Almutairi, Kholoud AlEnizi, Imad Tleyjeh
Publikováno v:
PloS one. 17(8)
Seroprevalence of SARS-CoV-2 IgG among health care workers (HCWs) is crucial to inform infection control programs. Conflicting reports have emerged on the longevity of SARS-CoV-2 IgG. Our objective is to describe the prevalence of SARS-CoV-2 IgG in H
Autor:
Nouf Al Mansour, Mohammed Al-Hazzaa, Mohammed Al-Zailaie, Fahmi M Al-Senani, Naim I. Kajtazi, Khalid Al Dossari, Ghadeer Al Momen, Imad Tleyjeh, Nehal Al Modarra, Jamal Muthana, Saud Al-Naaim, Ziyad AlMalki
Publikováno v:
Journal of Clinical Neurology and Neuroscience.
Autor:
Abdur R, Khan, Aref A, Bin Abdulhak, Mujeeb A, Sheikh, Sobia, Khan, Patricia J, Erwin, Imad, Tleyjeh, Sadik, Khuder, Ehab A, Eltahawy
Publikováno v:
JACC. Cardiovascular interventions. 6(12)
This study sought to perform a meta-analysis of randomized controlled trials comparing device closure with medical therapy in the prevention of recurrent neurological events in patients with cryptogenic stroke and patent foramen ovale.The optimal str
Autor:
Imad Tleyjeh
Publikováno v:
Archives of Internal Medicine. 170:42
Autor:
Imad Tleyjeh, Guido Valle
Publikováno v:
Heart. 94:1496-1496
Autor:
Alasmari, Faisal1,2 (AUTHOR) faalasmari@kfmc.med.sa, Mukahal, Mahmoud1 (AUTHOR), Alqurashi, Alaa Ashraf3 (AUTHOR), Huq, Molla4 (AUTHOR), Alabdrabalnabi, Fatima1 (AUTHOR), AlJurayyan, Abdullah5 (AUTHOR), Alkahtani, Shymaa Moshobab6 (AUTHOR), Assari, Fatimah Salem6 (AUTHOR), Bashaweeh, Rahaf6 (AUTHOR), Salam, Rana2 (AUTHOR), Aldera, Solaf1 (AUTHOR), Alkinani, Ohud Mohammed7 (AUTHOR), Almutairi, Talal8 (AUTHOR), AlEnizi, Kholoud9 (AUTHOR), Tleyjeh, Imad2 (AUTHOR)
Publikováno v:
PLoS ONE. 8/12/2022, Vol. 17 Issue 8, p1-15. 15p.
Autor:
Mir, Tanveer1,2 (AUTHOR) gr6723@wayne.edu, Uddin, Mohammed1 (AUTHOR), Qureshi, Waqas T.3 (AUTHOR), Regmi, Neelambuj4 (AUTHOR), Tleyjeh, Imad M.5,6 (AUTHOR), Saydain, Ghulam4 (AUTHOR)
Publikováno v:
Infectious Diseases & Therapy. Feb2022, Vol. 11 Issue 1, p305-321. 17p.
Autor:
Saheb Sharif‐Askari, Fatemeh, Ali Hussain Alsayed, Hawra, Tleyjeh, Imad, Saheb Sharif‐Askari, Narjes, Al Sayed Hussain, Ali, Saddik, Basema, Hamid, Qutayba, Halwani, Rabih
Publikováno v:
Clinical Pharmacology & Therapeutics; Dec2022, Vol. 112 Issue 6, p1214-1223, 10p